696 related articles for article (PubMed ID: 28356429)
1. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
[No Abstract] [Full Text] [Related]
2. WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.
Cyr Y; Wassef H; Bissonnette S; Lamantia V; Davignon J; Faraj M
J Lipid Res; 2016 Jun; 57(6):1074-85. PubMed ID: 27040450
[TBL] [Abstract][Full Text] [Related]
3. White adipose tissue apolipoprotein C-I secretion in relation to delayed plasma clearance of dietary fat in humans.
Wassef H; Salem H; Bissonnette S; Baass A; Dufour R; Davignon J; Faraj M
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2785-93. PubMed ID: 22995522
[TBL] [Abstract][Full Text] [Related]
4. Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue.
Bissonnette S; Salem H; Wassef H; Saint-Pierre N; Tardif A; Baass A; Dufour R; Faraj M
J Lipid Res; 2013 May; 54(5):1466-76. PubMed ID: 23417739
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
[TBL] [Abstract][Full Text] [Related]
6. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
Björkegren J; Karpe F; Milne RW; Hamsten A
J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
[TBL] [Abstract][Full Text] [Related]
7. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal.
Cohn JS; McNamara JR; Cohn SD; Ordovas JM; Schaefer EJ
J Lipid Res; 1988 Jul; 29(7):925-36. PubMed ID: 3411251
[TBL] [Abstract][Full Text] [Related]
8. Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state.
Chan DC; Wong AT; Pang J; Barrett PH; Watts GF
Clin Sci (Lond); 2015 Mar; 128(6):379-85. PubMed ID: 25291660
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
10. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism.
Chan DC; Watts GF; Somaratne R; Wasserman SM; Scott R; Barrett PHR
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1644-1655. PubMed ID: 29880491
[TBL] [Abstract][Full Text] [Related]
12. The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men.
Hamsten A; Silveira A; Boquist S; Tang R; Bond MG; de Faire U; Björkegren J
J Am Coll Cardiol; 2005 Apr; 45(7):1013-7. PubMed ID: 15808756
[TBL] [Abstract][Full Text] [Related]
13. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
[TBL] [Abstract][Full Text] [Related]
14. Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients.
Parhofer KG; Laubach E; Barrett PH
J Lipid Res; 2003 Jun; 44(6):1192-8. PubMed ID: 12671031
[TBL] [Abstract][Full Text] [Related]
15. Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state.
Genest J; Nguyen NH; Theroux P; Davignon J; Cohn JS
J Cardiovasc Pharmacol; 2000 Jan; 35(1):164-72. PubMed ID: 10630748
[TBL] [Abstract][Full Text] [Related]
16. Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.
Zheng C; Khoo C; Ikewaki K; Sacks FM
J Lipid Res; 2007 May; 48(5):1190-203. PubMed ID: 17314277
[TBL] [Abstract][Full Text] [Related]
17. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
Karpe F; Hellénius ML; Hamsten A
Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
[TBL] [Abstract][Full Text] [Related]
18. Postprandial changes in the distribution of apolipoprotein AIV between apolipoprotein B- and non apolipoprotein B-containing lipoproteins in obese women.
Ferrer F; Nazih H; Zaïr Y; Krempf M; Bard JM
Metabolism; 2003 Dec; 52(12):1537-41. PubMed ID: 14669151
[TBL] [Abstract][Full Text] [Related]
19. Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia.
Guan Y; Hou X; Tian P; Ren L; Tang Y; Song A; Zhao J; Gao L; Song G
Front Endocrinol (Lausanne); 2021; 12():646185. PubMed ID: 33967959
[TBL] [Abstract][Full Text] [Related]
20. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
Le NA; Innis-Whitehouse W; Li X; Bakker-Arkema R; Black D; Brown WV
Metabolism; 2000 Feb; 49(2):167-77. PubMed ID: 10690940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
